DiviDrip · IMUX

IMUX — Immunic, Inc.

IMUX is Immunic, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $12.74. Market cap: $174M. Capital Quality Rank: 11/100 — Systemic risk.

Stock snapshot

Price$12.74
Market cap$174M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)11 / 100 · Systemic risk
Shareholder buyback yield-30.00%
Altman Z-score zoneGrey

About IMUX

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.

Listed2014Employees95HQNew York, X1SectorHealthcareWebsiteimux.com

Related non-dividend companies

Other non-dividend stocks investors research alongside IMUX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is IMUX's current stock price?

IMUX (Immunic, Inc.) is currently trading at $12.74.

Does IMUX pay a dividend?

IMUX (Immunic, Inc.) does not currently pay a regular dividend.

What is IMUX's Capital Quality Rank?

IMUX has a Capital Quality Rank of 11/100 — Systemic risk. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track IMUX in DiviDrip

Add IMUX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow